Aaron M. Drucker

Focused update: Guidelines of care for the management of atopic dermatitis in adults

Living network meta-analysis to compare nemolizumab against other available targeted systemic treatments for atopic dermatitis

HLA-B Alleles With Shared Peptide Binding Specificities Define Global Risk of Co-trimoxazole-Induced Severe Cutaneous Adverse Drug Reactions

Systemic Immunomodulatory Treatments for Atopic Dermatitis

Targeted Systemic Therapies for Adults with Atopic Dermatitis: Selecting from Biologics and JAK Inhibitors

Towards a patient-centred definition for atopic dermatitis flare: a qualitative study of adults with atopic dermatitis

Consensus on a Patient-Centered Definition of Atopic Dermatitis Flare

Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies

Guidelines of care for the management of atopic dermatitis in adults with topical therapies

Comparing binary efficacy outcomes for systemic immunomodulatory treatments for atopic dermatitis in a living systematic review and network meta-analysis

Executive summary: Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies

Executive summary: American Academy of Dermatology guidelines of care for the management of atopic dermatitis in adults with topical therapies

An Assessment of Current Clinician-Reported and Patient-Reported Outcome Measures for Alopecia Areata: A Scoping Review

Association of Different Prescribing Patterns for Oral Corticosteroids With Fracture Preventive Care Among Older Adults in the UK and Ontario

Systemic Immunomodulatory Treatments for Atopic Dermatitis

American Academy of Dermatology Guidelines: Awareness of comorbidities associated with atopic dermatitis in adults

Systemic Therapy for Atopic Dermatitis in Older Adults and Adults With Comorbidities: A Scoping Review and International Eczema Council Survey

The effects of systemic immunomodulatory treatments on <scp>COVID</scp>‐19 outcomes in patients with atopic dermatitis: Results from the global <scp>SECURE‐AD</scp> registry

Systemic Immunomodulatory Treatments for Patients With Atopic Dermatitis

Core Outcome Set for Actinic Keratosis Clinical Trials

Conjunctivitis in atopic dermatitis patients with and without dupilumab therapy – international eczema council survey and opinion

When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council

Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement

Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative)

Evaluation of the measurement properties of symptom measurement instruments for atopic eczema: a systematic review

Measurement properties of quality-of-life measurement instruments for infants, children and adolescents with eczema: a systematic review

Measurement properties of quality of life measurement instruments for infants, children and adolescents with eczema: protocol for a systematic review

Measurement properties of adult quality‐of‐life measurement instruments for eczema: a systematic review